Germline pathogenic variants in 786 neuroblastoma patients
Jung Kim, Zalman Vaksman, Laura E. Egolf…·Sharon J. Diskin
This study identifies 13.9% of neuroblastoma patients with pathogenic germline variants in cancer predisposition genes, associated with worse survival and enriched in DNA repair genes like BARD1.